Adcytherix
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
Series A ·
Amount not disclosed in a source on record.
All 2 rounds ↓Signals
About Adcytherix
The company was founded by the previous founders of Emergence Therapeutics.
Adcytherix | 245 days from website to first raise on record
One step per dated milestone. Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
CD
Carsten Dehning FounderJE
Jack Elands Founder, Chief Executive Officersource: adcytherix.comJA
Jaime Arango Chief Financial OfficerJS
Jan Schellens Chief Medical Officer
Investors
AaMoon Fund
AAndera Partners
AAngelini Ventures
BBpifrance
DDawn Biopharma
KKurma Partners
PPontifax
PPureos Bioventures
RRA Capital Management
SSurveyor Capital
Companies like Adcytherix
PPhrontline Biopharma$40M Series A · Nov 2026
VVelosbioSeries B+ · Aug 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAdcendo$75M Series B+ · Apr 2026
TTubulis$360M Series B+ · Oct 2025TTNAX Biopharma
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/adcytherix (get a free API key).